Variable

BMI (kg/m²)

BSA (m²)

Count

Mean

SD

P-value^†

Mean

SD

P-value^†

Menopausal

Premenopausal

69

33.99

6.35

0.608

1.85

0.17

0.820

Postmenopausal

46

33.42

5.43

1.84

0.12

T staging

T1

24

33.1

6.0

0.705

1.84

0.15

0.581

T2

46

34.2

5.8

1.85

0.15

T3

39

33.3

6.6

1.83

0.17

T4

6

35.9

2.8

1.92

0.08

T stage

T1/T2

70

33.8

5.8

0.911

1.85

0.15

0.767

T3/T4

45

33.7

6.3

1.84

0.16

N stage

N0/N1

70

34.0

6.1

0.586

1.86

0.15

0.121

N2/N3

45

33.4

5.9

1.82

0.16

Tumor stage

Stage I/II

49

33.1

6.2

0.347

1.83

0.16

0.464

Stage III

66

34.2

5.8

1.85

0.15

ER

ER−

27

34.2

5.7

0.694

1.86

0.15

0.549

ER+

88

33.6

6.1

1.84

0.15

PR

PR−

39

33.7

5.5

0.920

1.84

0.16

0.936

PR+

76

33.8

6.2

1.85

0.15

HER2

HER2−

85

33.7

6.3

0.762

1.85

0.15

0.441

HER2+

30

34.0

5.1

1.83

0.15

Molecular subtype

HR+

69

33.7

6.4

0.841

1.85

0.15

0.841

HR+/HER2−

18

33.3

4.8

1.82

0.16

HER2+

12

35.2

5.4

1.84

0.14

TN

16

33.6

5.8

1.86

0.15